Jeffrey P. B. M. Braak

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 576 citations

Medicine, Oncology, Surgery +17

Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial

Robin A. Faber, R.P. Meijer, Daphne Droogh et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 88 citations · Full text

Medicine, Perioperative Medicine, Surgery +15

Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial

Wobbe O. de Steur, Romy M. van Amelsfoort, H.H. Hartgrink et al. · Annals of Oncology · 2020 · 67 citations · Full text

Medicine, Oncology, Surgery +17

Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial

Y.H.M. Claassen, H.H. Hartgrink, Johan L. Dikken et al. · European Journal of Surgical Oncology · 2018 · 54 citations

Medicine, Oncology, Surgery +14

Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial

Y.H.M. Claassen, Johanna W. van Sandick, H.H. Hartgrink et al. · British journal of surgery · 2018 · 50 citations · Full text

Medicine, Oncology, Surgery +14